BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 34215150)

  • 21. Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis.
    Bischof A; Papinutto N; Keshavan A; Rajesh A; Kirkish G; Zhang X; Mallott JM; Asteggiano C; Sacco S; Gundel TJ; Zhao C; Stern WA; Caverzasi E; Zhou Y; Gomez R; Ragan NR; Santaniello A; Zhu AH; Juwono J; Bevan CJ; Bove RM; Crabtree E; Gelfand JM; Goodin DS; Graves JS; Green AJ; Oksenberg JR; Waubant E; Wilson MR; Zamvil SS; ; Cree BAC; Hauser SL; Henry RG
    Ann Neurol; 2022 Feb; 91(2):268-281. PubMed ID: 34878197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spinal cord atrophy in anterior-posterior direction reflects impairment in multiple sclerosis.
    Lundell H; Svolgaard O; Dogonowski AM; Romme Christensen J; Selleberg F; Soelberg Sørensen P; Blinkenberg M; Siebner HR; Garde E
    Acta Neurol Scand; 2017 Oct; 136(4):330-337. PubMed ID: 28070886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal assessment of cervical spinal cord compartments in multiple sclerosis.
    Tsagkas C; Huck-Horvath A; Cagol A; Haas T; Amann M; Barakovic M; Ruberte E; Melie-Garcia L; Weigel M; Pezold S; Schlaeger R; Kuhle J; Sprenger T; Kappos L; Bieri O; Cattin P; Granziera C; Parmar K
    Mult Scler Relat Disord; 2023 Mar; 71():104545. PubMed ID: 36758461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.
    Schlaeger R; Papinutto N; Zhu AH; Lobach IV; Bevan CJ; Bucci M; Castellano A; Gelfand JM; Graves JS; Green AJ; Jordan KM; Keshavan A; Panara V; Stern WA; von Büdingen HC; Waubant E; Goodin DS; Cree BA; Hauser SL; Henry RG
    JAMA Neurol; 2015 Aug; 72(8):897-904. PubMed ID: 26053119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal spinal cord atrophy in multiple sclerosis using the generalized boundary shift integral.
    Moccia M; Prados F; Filippi M; Rocca MA; Valsasina P; Brownlee WJ; Zecca C; Gallo A; Rovira A; Gass A; Palace J; Lukas C; Vrenken H; Ourselin S; Gandini Wheeler-Kingshott CAM; Ciccarelli O; Barkhof F;
    Ann Neurol; 2019 Nov; 86(5):704-713. PubMed ID: 31385358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between cervical spinal cord morphometry and clinical disability in patients with multiple sclerosis.
    Celik NG; Karabulut AK; Fazliogullari Z; Gumus H; Cebeci H; Dogan NU
    Rev Assoc Med Bras (1992); 2023; 69(12):e20230949. PubMed ID: 37971136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disability.
    Kerbrat A; Gros C; Badji A; Bannier E; Galassi F; Combès B; Chouteau R; Labauge P; Ayrignac X; Carra-Dalliere C; Maranzano J; Granberg T; Ouellette R; Stawiarz L; Hillert J; Talbott J; Tachibana Y; Hori M; Kamiya K; Chougar L; Lefeuvre J; Reich DS; Nair G; Valsasina P; Rocca MA; Filippi M; Chu R; Bakshi R; Callot V; Pelletier J; Audoin B; Maarouf A; Collongues N; De Seze J; Edan G; Cohen-Adad J
    Brain; 2020 Jul; 143(7):2089-2105. PubMed ID: 32572488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosis.
    Cortese R; Tur C; Prados F; Schneider T; Kanber B; Moccia M; Wheeler-Kingshott CAG; Thompson AJ; Barkhof F; Ciccarelli O
    Mult Scler; 2021 Jan; 27(1):28-38. PubMed ID: 31961242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central nervous system atrophy predicts future dynamics of disability progression in a real-world multiple sclerosis cohort.
    Tsagkas C; Naegelin Y; Amann M; Papadopoulou A; Barro C; Chakravarty MM; Gaetano L; Wuerfel J; Kappos L; Kuhle J; Granziera C; Sprenger T; Magon S; Parmar K
    Eur J Neurol; 2021 Dec; 28(12):4153-4166. PubMed ID: 34487400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 3T MR imaging investigation of the topography of whole spinal cord atrophy in multiple sclerosis.
    Klein JP; Arora A; Neema M; Healy BC; Tauhid S; Goldberg-Zimring D; Chavarro-Nieto C; Stankiewicz JM; Cohen AB; Buckle GJ; Houtchens MK; Ceccarelli A; Dell'Oglio E; Guttmann CR; Alsop DC; Hackney DB; Bakshi R
    AJNR Am J Neuroradiol; 2011; 32(6):1138-42. PubMed ID: 21527570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis.
    Aymerich FX; Auger C; Alonso J; Alberich M; Sastre-Garriga J; Tintoré M; Montalban X; Rovira A
    AJNR Am J Neuroradiol; 2018 Feb; 39(2):399-404. PubMed ID: 29284602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep gray matter volume loss drives disability worsening in multiple sclerosis.
    Eshaghi A; Prados F; Brownlee WJ; Altmann DR; Tur C; Cardoso MJ; De Angelis F; van de Pavert SH; Cawley N; De Stefano N; Stromillo ML; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Vrenken H; Leurs CE; Killestein J; Pirpamer L; Enzinger C; Ourselin S; Wheeler-Kingshott CAMG; Chard D; Thompson AJ; Alexander DC; Barkhof F; Ciccarelli O;
    Ann Neurol; 2018 Feb; 83(2):210-222. PubMed ID: 29331092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A conventional and magnetization transfer MRI study of the cervical cord in patients with MS.
    Filippi M; Bozzali M; Horsfield MA; Rocca MA; Sormani MP; Iannucci G; Colombo B; Comi G
    Neurology; 2000 Jan; 54(1):207-13. PubMed ID: 10636149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diffusion tensor imaging of normal-appearing cervical spinal cords in patients with multiple sclerosis: Correlations with clinical evaluation and cerebral diffusion tensor imaging changes. Preliminary experience.
    Wolańczyk M; Bladowska J; Kołtowska A; Pokryszko-Dragan A; Podgórski P; Budrewicz S; Sąsiadek M
    Adv Clin Exp Med; 2020 Apr; 29(4):441-448. PubMed ID: 32369275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial.
    Lin X; Tench CR; Turner B; Blumhardt LD; Constantinescu CS
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1090-4. PubMed ID: 12876240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demyelinating lesions in the cervical cord in multiple sclerosis 10 years after onset of the disease. Correlation between MRI parameters and clinical course.
    Bonek R; Orlicka K; Maciejek Z
    Neurol Neurochir Pol; 2007; 41(3):229-33. PubMed ID: 17629816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo imaging of spinal cord atrophy in neuroinflammatory diseases.
    Liu W; Nair G; Vuolo L; Bakshi A; Massoud R; Reich DS; Jacobson S
    Ann Neurol; 2014 Sep; 76(3):370-8. PubMed ID: 25042583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.
    Kearney H; Miszkiel KA; Yiannakas MC; Altmann DR; Ciccarelli O; Miller DH
    Mult Scler; 2016 Jun; 22(7):910-20. PubMed ID: 26432854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.